Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 1381 AL 1395

Immunochemical detection of lipid hydroperoxide- and aldehyde-modified proteins in diseases

Sugiyama A, Sun J.

Subcell Biochem. 2014;77:115-25. doi: 10.1007/978-94-007-7920-4_10.

Predictive association of copper metabolism proteins with Alzheimer's disease and Parkinson's disease: a preliminary perspective

Pal A, Kumar A, Prasad R.

Biometals. 2014 Feb;27(1):25-31. doi: 10.1007/s10534-013-9702-7. Epub 2014 Jan 17.

Gene therapy and cell reprogramming for the aging brain: achievements and promise

Pardo J, Morel GR, Astiz M, Schwerdt JI, León ML, Rodríguez SS, Hereñú CB, Goya RG.

Curr Gene Ther. 2014 Feb;14(1):24-34. doi: 10.2174/1566523214666140120121733.

Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease

Overk CR, Masliah E.

Biochem Pharmacol. 2014 Apr 15;88(4):508-16. doi: 10.1016/j.bcp.2014.01.015. Epub 2014 Jan 21.

Grey matter changes in cognitively impaired Parkinson's disease patients

Rektorova I, Biundo R, Marecek R, Weis L, Aarsland D, Antonini A.

PLoS One. 2014 Jan 21;9(1):e85595. doi: 10.1371/journal.pone.0085595. eCollection 2014.

A claims data-based comparison of comorbidity in individuals with and without dementia

Bauer K, Schwarzkopf L, Graessel E, Holle R.

BMC Geriatr. 2014 Jan 28;14:10. doi: 10.1186/1471-2318-14-10.

Effects of gabapentin enacarbil on restless legs syndrome and leg pain in dementia with Lewy bodies

Fujishiro H.

Psychogeriatrics. 2014 Jun;14(2):132-4. doi: 10.1111/psyg.12043. Epub 2014 Feb 16.

Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses

Ibáñez K, Boullosa C, Tabarés-Seisdedos R, Baudot A, Valencia A.

PLoS Genet. 2014 Feb 20;10(2):e1004173. doi: 10.1371/journal.pgen.1004173. eCollection 2014 Feb.

Protein folding and misfolding in the neurodegenerative disorders: a review

Bolshette NB, Thakur KK, Bidkar AP, Trandafir C, Kumar P, Gogoi R.

Rev Neurol (Paris). 2014 Mar;170(3):151-61. doi: 10.1016/j.neurol.2013.11.002. Epub 2014 Mar 7.

Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study

Le Heron CJ, Wright SL, Melzer TR, Myall DJ, MacAskill MR, Livingston L, Keenan RJ, Watts R, Dalrymple-Alford JC, Anderson TJ.

J Cereb Blood Flow Metab. 2014 Jun;34(6):964-70. doi: 10.1038/jcbfm.2014.40. Epub 2014 Mar 12.

Olfactory dysfunction and dementia in Parkinson's disease

Takeda A, Baba T, Kikuchi A, Hasegawa T, Sugeno N, Konno M, Miura E, Mori E.

J Parkinsons Dis. 2014;4(2):181-7. doi: 10.3233/JPD-130277.

Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases

Hölscher C.

Biochem Soc Trans. 2014 Apr;42(2):593-9. doi: 10.1042/BST20140016.

Regulation of mitochondrial dynamics and cell fate

Dhingra R, Kirshenbaum LA.

Circ J. 2014;78(4):803-10. doi: 10.1253/circj.cj-14-0240. Epub 2014 Mar 20.

Mortality from Alzheimer's disease, Parkinson's disease, and dementias in France and Italy: a comparison using the multiple cause-of-death approach

Désesquelles A, Demuru E, Salvatore MA, Pappagallo M, Frova L, Meslé F, Egidi V.

J Aging Health. 2014 Mar;26(2):283-315. doi: 10.1177/0898264313514443.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias